Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.
Helleniq Energy has completed two photovoltaic parks in southern Romania with a combined capacity of 58 MW, marking the company's first operational renewable energy assets in the country. The projects are part of a 2023 agreement with Metlen for developing four solar projects totalling 211 MW.
Intesa Sanpaolo Bank Romania has appointed Anca Petcu as Chief Operations and Transformation Officer and Deputy CEO, following approval from the National Bank of Romania.
Patria Bank has signed a contract to sell its 99.9% stake in SAI Patria Asset Management to BRD Asset Management SAI for €5.5 million.
Romania's pharmaceutical sector demonstrates resilience despite fiscal consolidation and slowing economic growth, according to Allianz Trade's latest analysis.
Mark Twain International School (IS) is preparing to open a new flagship campus in Balotești, representing a €30 million investment in private education in Romania. The opening is scheduled for September 2028.